These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 17998225)

  • 21. Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group.
    Harris ST; Watts NB; Genant HK; McKeever CD; Hangartner T; Keller M; Chesnut CH; Brown J; Eriksen EF; Hoseyni MS; Axelrod DW; Miller PD
    JAMA; 1999 Oct; 282(14):1344-52. PubMed ID: 10527181
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Once-yearly zoledronic acid in older men compared with women with recent hip fracture.
    Boonen S; Orwoll E; Magaziner J; Colón-Emeric CS; Adachi JD; Bucci-Rechtweg C; Haentjens P; Kaufman JM; Rizzoli R; Vanderschueren D; Claessens F; Sermon A; Witvrouw R; Milisen K; Su G; Lyles KW;
    J Am Geriatr Soc; 2011 Nov; 59(11):2084-90. PubMed ID: 22091563
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fluoride salts are no better at preventing new vertebral fractures than calcium-vitamin D in postmenopausal osteoporosis: the FAVOStudy.
    Meunier PJ; Sebert JL; Reginster JY; Briancon D; Appelboom T; Netter P; Loeb G; Rouillon A; Barry S; Evreux JC; Avouac B; Marchandise X
    Osteoporos Int; 1998; 8(1):4-12. PubMed ID: 9692071
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Once-weekly risedronate for prevention of hip fracture in women with Parkinson's disease: a randomised controlled trial.
    Sato Y; Iwamoto J; Honda Y
    J Neurol Neurosurg Psychiatry; 2011 Dec; 82(12):1390-3. PubMed ID: 21825080
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effectiveness and safety of vitamin D in relation to bone health.
    Cranney A; Horsley T; O'Donnell S; Weiler H; Puil L; Ooi D; Atkinson S; Ward L; Moher D; Hanley D; Fang M; Yazdi F; Garritty C; Sampson M; Barrowman N; Tsertsvadze A; Mamaladze V
    Evid Rep Technol Assess (Full Rep); 2007 Aug; (158):1-235. PubMed ID: 18088161
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analysis.
    Tang BM; Eslick GD; Nowson C; Smith C; Bensoussan A
    Lancet; 2007 Aug; 370(9588):657-66. PubMed ID: 17720017
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis.
    Gillespie WJ; Avenell A; Henry DA; O'Connell DL; Robertson J
    Cochrane Database Syst Rev; 2001; (1):CD000227. PubMed ID: 11279685
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A claims database analysis of persistence with alendronate therapy and fracture risk in post-menopausal women with osteoporosis.
    Gold DT; Martin BC; Frytak JR; Amonkar MM; Cosman F
    Curr Med Res Opin; 2007 Mar; 23(3):585-94. PubMed ID: 17355739
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of vitamin D supplementation on musculoskeletal health: a systematic review, meta-analysis, and trial sequential analysis.
    Bolland MJ; Grey A; Avenell A
    Lancet Diabetes Endocrinol; 2018 Nov; 6(11):847-858. PubMed ID: 30293909
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clodronate reduces vertebral fracture risk in women with postmenopausal or secondary osteoporosis: results of a double-blind, placebo-controlled 3-year study.
    McCloskey E; Selby P; Davies M; Robinson J; Francis RM; Adams J; Kayan K; Beneton M; Jalava T; Pylkkänen L; Kenraali J; Aropuu S; Kanis JA
    J Bone Miner Res; 2004 May; 19(5):728-36. PubMed ID: 15068495
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and safety of once-yearly zoledronic acid in Japanese patients with primary osteoporosis: two-year results from a randomized placebo-controlled double-blind study (ZOledroNate treatment in Efficacy to osteoporosis; ZONE study).
    Nakamura T; Fukunaga M; Nakano T; Kishimoto H; Ito M; Hagino H; Sone T; Taguchi A; Tanaka S; Ohashi M; Ota Y; Shiraki M
    Osteoporos Int; 2017 Jan; 28(1):389-398. PubMed ID: 27631091
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vitamin D supplementation and the prevention of fractures and falls: results of a randomised trial in elderly people in residential accommodation.
    Law M; Withers H; Morris J; Anderson F
    Age Ageing; 2006 Sep; 35(5):482-6. PubMed ID: 16641143
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of ergocalciferol added to calcium on the risk of falls in elderly high-risk women.
    Prince RL; Austin N; Devine A; Dick IM; Bruce D; Zhu K
    Arch Intern Med; 2008 Jan; 168(1):103-8. PubMed ID: 18195202
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The prevention of hip fracture with risedronate and ergocalciferol plus calcium supplementation in elderly women with Alzheimer disease: a randomized controlled trial.
    Sato Y; Kanoko T; Satoh K; Iwamoto J
    Arch Intern Med; 2005 Aug 8-22; 165(15):1737-42. PubMed ID: 16087821
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A randomized double-blinded placebo controlled trial of ergocalciferol 40,000 versus 100,000 IU per week for vitamin D inadequacy in institutionalized postmenopausal women.
    Mueangpaisarn P; Chaiamnuay S
    Aging Clin Exp Res; 2020 Jan; 32(1):41-48. PubMed ID: 30784012
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of oral vitamin D2 yearly bolus on hip fracture risk in elderly women: a community primary prevention study.
    Rossini M; Alberti V; Flor L; Masiero L; Giannini S; Gatti D; Adami S
    Aging Clin Exp Res; 2004 Dec; 16(6):432-6. PubMed ID: 15739592
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of calcium supplementation on clinical fracture and bone structure: results of a 5-year, double-blind, placebo-controlled trial in elderly women.
    Prince RL; Devine A; Dhaliwal SS; Dick IM
    Arch Intern Med; 2006 Apr; 166(8):869-75. PubMed ID: 16636212
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Summary of AHRQ's comparative effectiveness review of treatment to prevent fractures in men and women with low bone density or osteoporosis: update of the 2007 report.
    Levis S; Theodore G
    J Manag Care Pharm; 2012 May; 18(4 Suppl B):S1-15; discussion S13. PubMed ID: 22716221
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 10-year probability of recurrent fractures following wrist and other osteoporotic fractures in a large clinical cohort: an analysis from the Manitoba Bone Density Program.
    Hodsman AB; Leslie WD; Tsang JF; Gamble GD
    Arch Intern Med; 2008 Nov; 168(20):2261-7. PubMed ID: 19001204
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevention of hip fractures by correcting calcium and vitamin D insufficiencies in elderly people.
    Meunier P
    Scand J Rheumatol Suppl; 1996; 103():75-8; discussion 79-80. PubMed ID: 8966494
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.